Differentiation therapy with hepatocyte nuclear factor 4α for patients with hepatocellular carcinoma.
APA
Yin C, Xu WP, et al. (2025). Differentiation therapy with hepatocyte nuclear factor 4α for patients with hepatocellular carcinoma.. Cell research, 35(9), 687-690. https://doi.org/10.1038/s41422-025-01142-3
MLA
Yin C, et al.. "Differentiation therapy with hepatocyte nuclear factor 4α for patients with hepatocellular carcinoma.." Cell research, vol. 35, no. 9, 2025, pp. 687-690.
PMID
40615636
같은 제1저자의 인용 많은 논문 (5)
- Body Contouring in Massive Weight Loss Patients Receiving Venous Thromboembolism Chemoprophylaxis: A Systematic Review.
- Targeting cancer stem cells: Dual-drug delivery systems and their role in cancer therapy.
- Extracellular Vesicles in Osteosarcoma: Mechanisms, Diagnostics and Therapeutic Applications.
- La-related protein 1 drives malignant progression and epithelial-mesenchymal transition in anaplastic thyroid carcinoma.
- The relation between Down syndrome and co-occurring conditions in children and young adults: A population-based cohort in Denmark, 1977-2016.